<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ding M</submitter><funding>Kunshan Traditional Chinese Medicine Science and Technology Development Fund Project</funding><funding>Kunshan Social Development Project</funding><funding>Nanjing University of Chinese Medicine Natural Science Foundation Project</funding><funding>Key Projects of Jiangsu Provincial Science</funding><funding>Suzhou Clinical Key Disease Diagnosis and Treatment Project</funding><pagination>51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12831259</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>21(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Non-alcoholic fatty liver disease (NAFLD), often accompanied by insulin resistance, obesity, and hyperlipidemia, is a challenging metabolic disorder to treat. Ge-Lian Qi-Shen Decoction, a traditional Chinese herbal formula, has been clinically used to alleviate symptoms associated with NAFLD, but its underlying mechanisms remain unclear.&lt;h4>Methods&lt;/h4>A NAFLD model was established in C57BL/6J mice using a high-fat diet (HFD). The effects of 4-week GQD intervention at different doses on NAFLD-related symptoms were assessed using biochemical analyses, pathological sections, and oral glucose tolerance tests. ELISA and qPCR were employed to investigate the impact of GQD on serum GLP-1 levels and intestinal Gcg gene expression in NAFLD mice. The direct stimulatory effects of</pubmed_abstract><journal>Chinese medicine</journal><pubmed_title>Targeting G-protein-coupled receptors and gut microbiota: Ge-Lian Qi-Shen decoction elevates GLP-1 to combat non-alcoholic fatty liver disease.</pubmed_title><pmcid>PMC12831259</pmcid><funding_grant_id>ZD202425</funding_grant_id><funding_grant_id>LCZX202229</funding_grant_id><funding_grant_id>XZR2024193</funding_grant_id><funding_grant_id>KS2233</funding_grant_id><funding_grant_id>KZYY2209</funding_grant_id><pubmed_authors>Peng H</pubmed_authors><pubmed_authors>Guo M</pubmed_authors><pubmed_authors>Luo Z</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Shan J</pubmed_authors><pubmed_authors>Xiao Z</pubmed_authors><pubmed_authors>Xu R</pubmed_authors><pubmed_authors>Xu C</pubmed_authors><pubmed_authors>Hou X</pubmed_authors><pubmed_authors>Ding M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Targeting G-protein-coupled receptors and gut microbiota: Ge-Lian Qi-Shen decoction elevates GLP-1 to combat non-alcoholic fatty liver disease.</name><description>&lt;h4>Background&lt;/h4>Non-alcoholic fatty liver disease (NAFLD), often accompanied by insulin resistance, obesity, and hyperlipidemia, is a challenging metabolic disorder to treat. Ge-Lian Qi-Shen Decoction, a traditional Chinese herbal formula, has been clinically used to alleviate symptoms associated with NAFLD, but its underlying mechanisms remain unclear.&lt;h4>Methods&lt;/h4>A NAFLD model was established in C57BL/6J mice using a high-fat diet (HFD). The effects of 4-week GQD intervention at different doses on NAFLD-related symptoms were assessed using biochemical analyses, pathological sections, and oral glucose tolerance tests. ELISA and qPCR were employed to investigate the impact of GQD on serum GLP-1 levels and intestinal Gcg gene expression in NAFLD mice. The direct stimulatory effects of</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Jan</publication><modification>2026-06-13T05:17:32.251Z</modification><creation>2026-06-13T03:08:38.203Z</creation></dates><accession>S-EPMC12831259</accession><cross_references><pubmed>41580820</pubmed><doi>10.1186/s13020-025-01305-9</doi></cross_references></HashMap>